Hugo Gizardin-Fredon

Mr. Hugo Gizardin-Fredon

CNRS, Strasbourg, Grand Est, France
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MAMegane K. Aebischer
Megane K. Aebischer
HGHugo Gizardin-Fredon
Hugo Gizardin-Fredon
HLHonorine Lardeux
Honorine Lardeux
DKDominik Kochardt
Dominik Kochardt
CECarsten Elger
Carsten Elger
VDValentina D'Atri
Valentina D'Atri
Gene therapy is opening unprecedented opportunities for novel therapeutic approaches. Based on the concept of rescuing function mutations by co-expressing the correct gene to allow biological functions to be restored, it requires the use of viral vectors to ensure the proper delivery of therapeutic genes. In this context, recombinant adeno-associated viruses (rAAV) are the most widely used vectors. Their biomanufacturing process requires the insertion of the therapeutic gene into the rAAV (full capsids). However, a percentage of rAAV that do not contain the desired gene (empty capsids), as well as partly filled capsids, might also be produced, potentially impacting the efficiency of the therapy. Therefore, the determination of the rAAV capsids’ full/empty ratio needs to be monitored to ensure consistent product quality and efficacy. Anion-exchange chromatography (AEX) can serve this need. In this contribution, thorough AEX method development, including a mobile phase, a stationary phase and gradient conditions, has highlighted its potential in supporting gene therapy. Taking advantage of the fact that viral capsids follow an “on/off” retention behavior, the application of a step gradient approach to the rAAV serotype 8 (rAAV8) allowed the unprecedented separation of rAAV8 full/empty capsids, with a resolution gain of 3.7 as compared to the resolution obtained with a fully optimized linear gradient. Finally, the developed analytical approach allowed a precise and accurate baseline separation and quantification of full and empty rAAV8 capsids, with the potential to be applied as a high-throughput quality control (QC) method.

25 April 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHugo Gizardin-Fredon
Hugo Gizardin-Fredon
PSPaulo E. Santo
Paulo E. Santo
MCMarie-Eve Chagot
Marie-Eve Chagot
Bruno CHARPENTIERBruno CHARPENTIER
Bruno CHARPENTIER
TBTiago M. Bandeiras
Tiago M. Bandeiras
SSSarah Sanglier-Cianférani
Sarah Sanglier-Cianférani
Chemical cross-linking reactions (XL) are an important strategy for studying protein-protein interactions (PPIs), including low abundant sub-complexes, in structural biology. However, choosing XL reagents and conditions is laborious and mostly limited to analysis of protein assemblies that can be resolved using SDS-PAGE. To overcome these limitations, we develop here a denaturing mass photometry (dMP) method for fast, reliable and user-friendly optimization and monitoring of chemical XL reactions. The dMP is a robust 2-step protocol that ensures 95% of irreversible denaturation within only 5 min. We show that dMP provides accurate mass identification across a broad mass range (30 kDa–5 MDa) along with direct label-free relative quantification of all coexisting XL species (sub-complexes and aggregates). We compare dMP with SDS-PAGE and observe that, unlike the benchmark, dMP is time-efficient (3 min/triplicate), requires significantly less material (20–100×) and affords single molecule sensitivity. To illustrate its utility for routine structural biology applications, we show that dMP affords screening of 20 XL conditions in 1 h, accurately identifying and quantifying all coexisting species. Taken together, we anticipate that dMP will have an impact on ability to structurally characterize more PPIs and macromolecular assemblies, expected final complexes but also sub-complexes that form en route.

10 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPaulo E. Santo
Paulo E. Santo
MCMarie-Eve Chagot
Marie-Eve Chagot
HGHugo Gizardin-Fredon
Hugo Gizardin-Fredon
MLMarie Ley
Marie Ley
TCThomas Chenuel
Thomas Chenuel
XMXavier MANIVAL
Xavier MANIVAL
R2SP belongs to the R2TP-like quaternary chaperone family and consists of RUVBL1/RUVBL2 AAA+ ATPases, which powers the machinery, and SPAG1 and PIH1D2 adapter proteins that engage specific clients to promote their quaternary assembly. However, little is known about the structure of R2SP and the precise mode of action of these R2TP-like complexes. Here, we combined biochemical (ATPase and fluorescence polarization assays) and structural approaches (NMR, structural mass spectrometry, cryo-EM) to investigate the 3D organization of the R2SP complex, its mode of assembly and ATPase activity. Together with our binding, mutational and kinetic studies, these results led us to propose a model in which SPAG1 and PIH1D2 bind and cooperatively engage RUVBL1/RUVBL2 to produce R2SP. This reveals a 3D structure close to the canonical R2TP complex but also highlights differences in RUVBL1/RUVBL2 ATPase activity, as well as the cooperative binding of SPAG1 and PIH1D2 to this catalytic core that may explain functional difference between the two systems.

28 January 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
PSPaulo E. Santo
Paulo E. Santo
MCMarie-Eve Chagot
Marie-Eve Chagot
HGHugo Gizardin-Fredon
Hugo Gizardin-Fredon
MLMarie Ley
Marie Ley
TCThomas Chenuel
Thomas Chenuel
XMXavier MANIVAL
Xavier MANIVAL
The human R2SP complex belongs to the R2TP-like quaternary chaperone family and consists of RUVBL1, RUVBL2, SPAG1 and PIH1D2. R2SP is crucial for the correct assembly of motile cilia (SPAG1 null mutations cause Primary Ciliary Dyskinesia) and the organization of the synaptic zone. RUVBL1/2 ATPases are the powerhouse of this molecular machinery, while SPAG1 and PIH1D2 would be adaptors that interact with specific clients to promote their quaternary assembly. Despite these functional data, little is known about the structure of R2SP and the precise mode of action of these R2TP-like complexes. We have combined biochemical and structural approaches (NMR, structural mass spectrometry and cryo-EM) to investigate the 3D organization of the human R2SP complex, its mode of assembly and ATPase activity. Our study reveals a three-dimensional structure similar to that of the canonical R2TP complex, but also highlights differences in the mode of action of its RUVBL1/2 ATPase core as well as the binding of its adaptors SPAG1 and PIH1D2.

27 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JBJohan Busselez
Johan Busselez
GKGeraldine Koenig
Geraldine Koenig
CDCarine Dominique
Carine Dominique
TKTorben Klos
Torben Klos
DVDeepika Velayudhan
Deepika Velayudhan
HSHelgo Schmidt
Helgo Schmidt
The ribosome maturation factor Rea1 (or Midasin) catalyses the removal of assembly factors from large ribosomal subunit precursors and promotes their export from the nucleus to the cytosol. Rea1 consists of nearly 5000 amino-acid residues and belongs to the AAA+ protein family. It consists of a ring of six AAA+ domains from which the ≈1700 amino-acid residue linker emerges that is subdivided into stem, middle and top domains. A flexible and unstructured D/E rich region connects the linker top to a MIDAS (metal ion dependent adhesion site) domain, which is able to bind the assembly factor substrates. Despite its key importance for ribosome maturation, the mechanism driving assembly factor removal by Rea1 is still poorly understood. Here we demonstrate that the Rea1 linker is essential for assembly factor removal. It rotates and swings towards the AAA+ ring following a complex remodelling scheme involving nucleotide independent as well as nucleotide dependent steps. ATP-hydrolysis is required to engage the linker with the AAA+ ring and ultimately with the AAA+ ring docked MIDAS domain. The interaction between the linker top and the MIDAS domain allows direct force transmission for assembly factor removal.

9 April 2026
Verified
Thesis
Closed access
HGHugo Gizardin-Fredon
Hugo Gizardin-Fredon
Vers des protocoles innovants en pontage chimique suivi par spectrométrie de masse (XL-MS) pour l’étude des interactions protéiques in-vitro et in-situ: Cette thèse présente des développements méthodologiques en pontage chimique couplé à la spectrométrie de masse (XL-MS) pour l’étude des interactions protéines-protéines. Une approche innovante de photométrie de masse dénaturante a d’abord été mise au point pour suivre les réactions de pontage. L’automatisation de la préparation des échantillons et l’usage du réactif enrichissable PhoX ont ensuite permis l’analyse de conformations peu abondantes. Une méthode de fractionnement en phase gazeuse basée sur la mobilité ionique FAIMS a été développée, atteignant des performances proches de l’enrichissement en solution. Ces différentes avancées ont été appliquées à l’étude structurale des complexes RuvBL1-RuvBL2 (R1R2) dans un cadre collaboratif international incluant R1R2-SPAG1-PIH1D2, R1R2-SHQ1-DKC1 et R1R2-NONO. Enfin, l’application du XL-MS a été étendue aux protéomes entiers et in-vivo grâce au développement d’un fractionnement automatisé en solution et l’extension de notre approche FAIMS.